BRIEF

on OXURION (EBR:OXUR)

Oxurion receives a transparency notification from Atlas Special Opportunities II LLC

Stock price chart of OXURION (EBR:OXUR) showing fluctuations.

Leuven, Belgium – On November 20, 2025, Oxurion NV (Euronext Brussels: OXUR) announced the receipt of a transparency notification in accordance with Belgian law. Atlas Special Opportunities II LLC sold voting shares, reducing its stake to 9,352,288 shares, below the 15% threshold of the 62,598,034 shares issued as of November 18, 2025.

Oxurion, based in Leuven, focuses on acquiring majority stakes in promising European pharmaceutical contract manufacturers. The company aims to build an integrated group of contract manufacturers serving the healthcare sector.

In the context of investing in digital assets, Oxurion warns of risks related to volatility, uncertain regulation and cybersecurity that could affect the return on planned investments in Bitcoin and Ethereum.

R. P.

Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all OXURION news